News

For all we know about multiple sclerosis (MS) – a chronic disease where a person’s immune system attacks their central nervous system and causes fatigue, bladder issues and pain, among other symptoms – there are still a lot of misconceptions around the condition. Read on to learn what’s fact and what’s fiction when it comes to MS.

For neurologists working with patients with Alzheimer’s disease, the road to actual treatment options has been long and paved with setbacks.

But that is changing for some patients. The Food and Drug Administration recently granted full approval to Leqembi® (lecanemab), the first disease-modifying treatment fully approved for patients in the early stages of Alzheimer’s disease. The development of this new drug offers hope to patients and may have lasting impacts on how physicians approach treatment.